Indian Cisplatin Exporters: Complete Supplier Ranking with Market Share — 584 Manufacturers (2026) — TransData Nexus

Q: Who is the largest cisplatin buyer importing from India?

UKRPHARMGROUP LLC (HUNGARY) is the largest cisplatin importer from India with a 10.1% market share and import value of $1.3M.

Q: How many cisplatin buyers import from India?

There are 584 active cisplatin buyers importing from India, with a combined import market of $12.8M across 1,701 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top cisplatin buyers from India?

The top 5 cisplatin buyers — UKRPHARMGROUP LLC, FRESENIUS KABI TAIWAN LTD., CSP MYLAN IRELAND LTD, FRESENIUS KABI TAIWAN LTD.,, XXCORXXHEAXXHCAXX INXX — together control 24.3% of total cisplatin import value from India.

Suresh Sormare

Cisplatin

India Pharmaceutical Trade Intelligence

$12.8M233 Suppliers130 CountriesHS 30049047

ExportsIndia → TAIWAN12.4%India → HUNGARY10.7%

ImportsGERMANY → India$9.5K UNITED STATES → India$2.3K

#1 Supplier: FRESENIUS KABI

Market Analysis: Top Importing Countries & Their Importers

1Taiwan

Taiwan emerges as the first largest importing country, achieving a total trade value of $1.6M through 20 shipments. This represents a market share of 12.4% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Taiwan has a diverse importer base, with their top importers including:

• FRESENIUS KABI TAIWAN LTD. - $680.8K (42.8% of country's total business)

• FRESENIUS KABI TAIWAN LTD., - $347.3K (21.8% of country's total business)

• FRESENIUS KABI TAIWAN LIMITED - $287.6K (18.1% of country's total business)

• FRESENIUS KABI TAIWAN LTD - $275.8K (17.3% of country's total business)

Key Insight: Taiwan demonstrates strong market positioning with an average shipment value of $79.6K, indicating premium pricing strategy compared to the market average of $7.6K.

Taiwan is a key market for Cisplatin imports, representing 12.4% of total trade value.

Primary Market

Secondary Market

2Hungary

Buyer Segment Analysis

TransData Nexus Cisplatin buyer market intelligence

1Buyer Segment Analysis

The importers of Cisplatin from India can be categorized into several segments:

1. Pharmaceutical Distributors: Entities like UKRPHARMGROUP LLC (Hungary) and FRESENIUS KABI TAIWAN LTD. (Taiwan) fall into this category. These distributors procure large volumes of Cisplatin to supply to various healthcare providers, including hospitals and clinics. Their purchasing patterns are characterized by bulk orders to meet the consistent demand from their client base.

2. Contract Manufacturers: Companies such as CSP MYLAN IRELAND LTD (France) and SCIEGEN PHARMACEUTICALS INC (United States) are contract manufacturers. They import Cisplatin as an active pharmaceutical ingredient (API) for formulation into finished dosage forms. Their procurement is typically aligned with production schedules and client contracts, leading to periodic, large-scale purchases.

3. Hospital Groups: Entities like FRESENIUS KABI (THAILAND) LTD (Thailand) represent hospital groups that import Cisplatin directly for use within their network of healthcare facilities. Their buying behavior is driven by patient treatment needs, resulting in regular, moderate-sized orders to maintain adequate stock levels.

4. Re-exporters: Some companies, such as H B C L (Vietnam), may act as re-exporters, importing Cisplatin for distribution to neighboring countries. Their order patterns can be irregular, influenced by regional demand fluctuations and trade agreements.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

TransData Nexus Research · Government and regulatory sources

Country-Specific Import Regulations

TransData Nexus Cisplatin buyer market intelligence

1Country-Specific Import Regulations

Taiwan

1. Regulatory Authority: Taiwan Food and Drug Administration (TFDA).

2. Import Registration Process: Importers must submit a drug registration application to the TFDA, including documentation on product quality, safety, and efficacy.

3. Estimated Timeline: The registration process typically takes 12 to 18 months.

4. Import Tariff/Duty: Pharmaceutical products under HS code 30049047 are generally subject to a 0% import duty in Taiwan.

Hungary

1. Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).

2. Import Registration Process: Applicants must submit a marketing authorization application to OGYÉI, providing comprehensive data on the drug's quality, safety, and efficacy.

3. Estimated Timeline: The process usually takes 210 days, as per European Medicines Agency (EMA) guidelines.

4. Import Tariff/Duty: As an EU member, Hungary applies a 0% import duty on pharmaceutical products under HS code 30049047.

France

1. Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).

2. Import Registration Process: Importers must obtain a marketing authorization from ANSM, involving submission of a dossier detailing the drug's quality, safety, and efficacy.

3. Estimated Timeline: The evaluation process typically takes 210 days, in line with EMA standards.

4. Import Tariff/Duty: France, as part of the EU, imposes a 0% import duty on pharmaceutical products under HS code 30049047.

United States

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must submit a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) to the FDA, providing comprehensive data on the drug's quality, safety, and efficacy.

Demand Drivers & Market Opportunity

TransData Nexus Cisplatin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Cisplatin in importing countries is primarily driven by the prevalence of cancers for which Cisplatin is a standard treatment, such as testicular, ovarian, bladder, and lung cancers. According to the World Health Organization (WHO), cancer remains a leading cause of morbidity and mortality worldwide, with approximately 19.3 million new cases and 10 million cancer-related deaths reported in 2020. This high disease burden necessitates the continuous procurement of effective chemotherapeutic agents like Cisplatin.

Government healthcare programs and the expansion of universal health coverage also significantly influence Cisplatin demand. Many countries have incorporated Cisplatin into their national essential medicines lists, aligning with the WHO Essential Medicines List, which includes Cisplatin as a core medicine for cancer treatment. This inclusion often leads to tender-based purchasing mechanisms, where governments or large healthcare providers issue tenders to procure substantial quantities of Cisplatin, ensuring its availability in public healthcare facilities. The presence of 584 buyers across 130 countries, as per our data, underscores the global reliance on Cisplatin and highlights the market opportunities for suppliers.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Cisplatin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest cisplatin buyer importing from India?

Based on import volume and value, UKRPHARMGROUP LLC (HUNGARY) leads with $1.3M in imports and a 10.1% market share — the highest of any single cisplatin importer. FRESENIUS KABI TAIWAN LTD. (TAIWAN) and CSP MYLAN IRELAND LTD (FRANCE) are the next largest buyers.

QHow many companies buy cisplatin from India?

There are 584 active cisplatin buyers importing from India, with a combined market of $12.8M across 1,701 shipments to 130 countries. The top 5 buyers hold 24.3% of total import value, while the remaining 579 buyers handle the other 75.7%.

QWhich countries import the most cisplatin from India?

The top importing countries for cisplatin from India are Taiwan (12.4%), Hungary (10.7%), France (7.2%), United States (6.9%), Thailand (6.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of cisplatin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for cisplatin from India?

The average import transaction value for cisplatin from India is $7.6K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Cisplatin buyer market intelligence

1Buyer Segment Analysis

The importers of Cisplatin from India can be categorized into several segments:

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

TransData Nexus Research · Government and regulatory sources

Country-Specific Import Regulations

TransData Nexus Cisplatin buyer market intelligence

1Country-Specific Import Regulations

Taiwan

1. Regulatory Authority: Taiwan Food and Drug Administration (TFDA).

2. Import Registration Process: Importers must submit a drug registration application to the TFDA, including documentation on product quality, safety, and efficacy.

3. Estimated Timeline: The registration process typically takes 12 to 18 months.

4. Import Tariff/Duty: Pharmaceutical products under HS code 30049047 are generally subject to a 0% import duty in Taiwan.

Hungary

1. Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).

2. Import Registration Process: Applicants must submit a marketing authorization application to OGYÉI, providing comprehensive data on the drug's quality, safety, and efficacy.

3. Estimated Timeline: The process usually takes 210 days, as per European Medicines Agency (EMA) guidelines.

4. Import Tariff/Duty: As an EU member, Hungary applies a 0% import duty on pharmaceutical products under HS code 30049047.

France

1. Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).

2. Import Registration Process: Importers must obtain a marketing authorization from ANSM, involving submission of a dossier detailing the drug's quality, safety, and efficacy.

3. Estimated Timeline: The evaluation process typically takes 210 days, in line with EMA standards.

4. Import Tariff/Duty: France, as part of the EU, imposes a 0% import duty on pharmaceutical products under HS code 30049047.

United States

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

Demand Drivers & Market Opportunity

TransData Nexus Cisplatin buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cisplatin

Cisplatin

Who Buys Cisplatin from India — 584 Importers Behind a $12.8M Market

Top Cisplatin Importers — Ranked by Import Value

Top Cisplatin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Cisplatin — and from which countries?

Cisplatin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Taiwan

2Hungary

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Cisplatin Buyers & Importers

QWho is the largest cisplatin buyer importing from India?

QHow many companies buy cisplatin from India?

QWhich countries import the most cisplatin from India?

QWhat is the average import order value for cisplatin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3France

4United States

5Thailand

Analysis Methodology